Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizhi Lv

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Biochemical and Molecular Toxicology|June 23, 2023
Upregulation of lncRNA PTOV1-AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR-505Xiaobin Chi, Zhijian Chen, Yongbiao Chen, et al.
Current Cancer Drug Targets|September 3, 2022
BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular CarcinomaZhelong Jiang, Zhihong Wei, Jianwei Chen, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Effectiveness and Safety of Different Patch Materials for Supravalvar Aortic Stenosis (Middle-Term Outcomes)Xinyue Lang, Lizhi Lv, Simeng Zhang, et al.
Oncology Letters|February 14, 2018
Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinomaYi Cao, Zhelong Jiang, Shaohu Wang, et al.
Cardiology Research and Practice|April 18, 2020
Omentin-1 Ameliorated Free Fatty Acid-Induced Impairment in Proliferation, Migration, and Inflammatory States of HUVECsYubin Chen, Fen Liu, Fei Han, et al.
Oncology Letters|August 22, 2018
Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in ChinaRuisheng Ke, Lizhi Lv, Jiayan Li, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Effectiveness and Safety of Mitral Valve Plasty in Patients with an Anomalous Origin of the Coronary Artery from the Pulmonary ArteryLizhi Lv, Xinyue Lang, Simeng Zhang, et al.
Frontiers in Oncology|May 1, 2023
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinomaChengkai Yang, Huaxiang Wang, Jianyong Liu, et al.
Cell Biochemistry and Biophysics|February 23, 2022
Immune Analysis and Small Molecule Drug Prediction of Hepatocellular Carcinoma Based on Single Sample Gene Set Enrichment AnalysisXinghua Huang, Huanzhang Hu, Jianyong Liu, et al.
Journal of Clinical and Translational Hepatology|November 15, 2024
Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and ExperimentsXiaobin Chi, Zhijian Chen, Jianda Yu, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Biochemical and Molecular Toxicology|June 23, 2023
Upregulation of lncRNA PTOV1-AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR-505Xiaobin Chi, Zhijian Chen, Yongbiao Chen, et al.
Current Cancer Drug Targets|September 3, 2022
BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular CarcinomaZhelong Jiang, Zhihong Wei, Jianwei Chen, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Effectiveness and Safety of Different Patch Materials for Supravalvar Aortic Stenosis (Middle-Term Outcomes)Xinyue Lang, Lizhi Lv, Simeng Zhang, et al.
Oncology Letters|February 14, 2018
Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinomaYi Cao, Zhelong Jiang, Shaohu Wang, et al.
Cardiology Research and Practice|April 18, 2020
Omentin-1 Ameliorated Free Fatty Acid-Induced Impairment in Proliferation, Migration, and Inflammatory States of HUVECsYubin Chen, Fen Liu, Fei Han, et al.
Oncology Letters|August 22, 2018
Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in ChinaRuisheng Ke, Lizhi Lv, Jiayan Li, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Effectiveness and Safety of Mitral Valve Plasty in Patients with an Anomalous Origin of the Coronary Artery from the Pulmonary ArteryLizhi Lv, Xinyue Lang, Simeng Zhang, et al.
Frontiers in Oncology|May 1, 2023
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinomaChengkai Yang, Huaxiang Wang, Jianyong Liu, et al.
Cell Biochemistry and Biophysics|February 23, 2022
Immune Analysis and Small Molecule Drug Prediction of Hepatocellular Carcinoma Based on Single Sample Gene Set Enrichment AnalysisXinghua Huang, Huanzhang Hu, Jianyong Liu, et al.
Journal of Clinical and Translational Hepatology|November 15, 2024
Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and ExperimentsXiaobin Chi, Zhijian Chen, Jianda Yu, et al.
Pageof 6